RAMIPRIL
Generic: RAMIPRIL
Zydus Lifesciences LimitedManufacturer
ORALRoute
RAMIPRILActive Substance
2008-09-02Original Approval
RAMIPRIL is FDA application ANDA078832, sponsored by ZYDUS PHARMS USA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2024-10-23
Ramipril Capsules USP 10 mg, a) 90 count (NDC 68180-591-09), b) 100 count NDC 68180-591-01), and c) 500 count (NDC 68180CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor
Class II2026-08-24
Ramipril Capsules USP, 10 mg, packaged in a) 100 Capsules (NDC 76282-673-01) and b) 500 Capsules (NDC 76282-673-05) bottFailed Impurities/Degradation Specifications: OOS result obtained for a process impurity, dicyclohex
Class II2024-10-23
Ramipril Capsules USP 2.5 mg, a) 90 count (NDC 68180-589-09), b) 100 count NDC 68180-589-01), and c) 500 count (NDC 6818CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor
Class II2024-10-23
Ramipril Capsules USP 5 mg, a) 90 count (NDC 68180-590-09), b) 100 count NDC 68180-590-01), and c) 500 count (NDC 68180-CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor
Top Reported Reactions
1
DYSPNOEA
8,475 reports
2
FATIGUE
8,326 reports
3
NAUSEA
7,673 reports
4
DIARRHOEA
7,307 reports
5
OFF LABEL USE
6,993 reports
6
DIZZINESS
6,908 reports
7
DRUG INEFFECTIVE
6,700 reports
8
VOMITING
6,431 reports
9
PAIN
6,031 reports
10
HEADACHE
5,750 reports